NASDAQ:SCMP

(SCMP) (SCMP) Stock Price, News & Analysis

Notice: This company has been marked as potentially delisted and may not be actively trading.
Today's Range
$18.00
$18.00
50-Day Range
$18.00
$18.00
52-Week Range
$9.30
$18.75
Volume
303,068 shs
Average Volume
2.56 million shs
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
SCMP stock logo

About (SCMP) Stock (NASDAQ:SCMP)

Sucampo Pharmaceuticals, Inc. is a biopharmaceutical company. The Company is focused on the development and commercialization of pharmaceutical products. Its primary focus areas are gastroenterology, ophthalmology and oncology-related disorders. Its product candidates include VTS-270, Lubiprostone (AMITIZA), Unoprostone is opropyl (RESCULA) and CPP-1X/sulindac combination product. VTS-270 is an investigational drug under clinical study for the treatment of Niemann-Pick Disease Type C-1, an ultra-orphan, progressive and fatal disease. AMITIZA is a ClC-2 chloride channel activator, which has been approved for three indications that cover distinct patient types: chronic idiopathic constipation, irritable bowel syndrome with constipation, and opioid-induced constipation. RESCULA is a Big Potassium channel activator used to lower intraocular pressure. CPP-1X/sulindac combination product is meant for the treatment of familial adenomatous polyposis (FAP).

SCMP Stock News Headlines

SHOCKING Crypto Leak…
A shocking leak has revealed tech giant Microsoft's plans to add crypto support to future products. If the plans in these leaked internal documents pan out, we could see prices skyrocket for Bitcoin, Ethereum, XRP and MORE… The coupling of gaming and cryptocurrency could absolutely transform digital finance as we know it in 2024.
SHOCKING Crypto Leak…
A shocking leak has revealed tech giant Microsoft's plans to add crypto support to future products. If the plans in these leaked internal documents pan out, we could see prices skyrocket for Bitcoin, Ethereum, XRP and MORE… The coupling of gaming and cryptocurrency could absolutely transform digital finance as we know it in 2024.
See More Headlines
Receive SCMP Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for (SCMP) and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
11/01/2017
Today
4/22/2024

Industry, Sector and Symbol

Sector
N/A
Industry
N/A
Sub-Industry
Pharmaceuticals
Current Symbol
NASDAQ:SCMP
CUSIP
86490910
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A

Miscellaneous

Free Float
N/A
Optionable
Not Optionable
Beta
N/A
Investing Strategies To Help Grow Your Retirement Income Cover

Need to stretch out your 401K or Roth IRA plan? Use these time-tested investing strategies to grow the monthly retirement income that your stock portfolio generates.

Get This Free Report

Key Executives

  • Peter S. Greenleaf (Age 47)
    Chairman of the Board, Chief Executive Officer
  • Peter P. Pfreundschuh CPA (Age 48)
    Chief Financial Officer
  • Max Donley (Age 48)
    Executive Vice President of Global Human Resources, Information Technology and Strategy
  • Matthias Alder (Age 52)
    Executive Vice President
  • Peter A. Kiener Ph.D. (Age 64)
    Chief Scientific Officer
  • Alex Driggs (Age 41)
    General Counsel, Corporate Secretary
  • Peter Lichtlen M.D. (Age 47)
    Ph.D., Chief Medical Officer
  • John H. Johnson (Age 58)
    Lead Independent Director
  • Paul R. Edick (Age 62)
    Director
  • Daniel P. Getman Ph.D. (Age 59)
    Director

SCMP Stock Analysis - Frequently Asked Questions

How were (SCMP)'s earnings last quarter?

(SCMP) (NASDAQ:SCMP) issued its quarterly earnings data on Wednesday, November, 1st. The biopharmaceutical company reported $0.27 EPS for the quarter, topping the consensus estimate of $0.25 by $0.02. The biopharmaceutical company had revenue of $61.27 million for the quarter, compared to analysts' expectations of $58.05 million. The firm's revenue for the quarter was up 5.9% compared to the same quarter last year. During the same period in the previous year, the firm posted $0.30 EPS.

What other stocks do shareholders of (SCMP) own?

Based on aggregate information from My MarketBeat watchlists, some companies that other (SCMP) investors own include XOMA (XOMA), SentinelOne (S), Alnylam Pharmaceuticals (ALNY), Teekay Tankers (TNK), Xenon Pharmaceuticals (XENE), Gilead Sciences (GILD), OPKO Health (OPK), Cisco Systems (CSCO), Infinera (INFN) and Micron Technology (MU).

This page (NASDAQ:SCMP) was last updated on 4/23/2024 by MarketBeat.com Staff

From Our Partners